The Boston Business Journal reports febit Inc., a DNA analysis technology firm, is slashing its Boston-area workforce by 60 percent.
The German-based bio-tech company, founded in 2005, employs between 90 and 100 people at its Lexington center, which means up to 60 people could lose their jobs.
According to the report, the cuts are the result of a shift in febit’s focus to blood-based microRNA biomarker discovery rather than genomics services.
“We are grateful to febit’s employees who developed the instruments business and successfully ran the genomics services,” Co-CEO Jochen Kohlhaas said in a press release today.
Also as part of the restructuring, CEO Cord Staehler resigned from the company.